Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
Kuriyama
R
R
Renal Center, Ohme Municipal General Hospital, Tokyo, Japan.
Kogure
H
H
Itoh
S
S
Kikuchi
K
K
Ichikawa
N
N
Nomura
Y
Y
Degawa
H
H
Meigata
K
K
Watanabe
K
K
Beck
Y
Y
Tomikawa
S
S
Nagao
T
T
Uchida
H
H
D000328:Adult; D000740:Anemia / Q000139:chemically induced* / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000150:complications; D011994:Recombinant Proteins / Q000627:therapeutic use; D012086:Reoperation; D014019:Tissue Donors
D000806:Angiotensin-Converting Enzyme Inhibitors; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D004656:Enalapril; D001379:Azathioprine